UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations

Expert opinion on drug metabolism & toxicology, 2016-05, Vol.12 (5), p.555-565

2016

Volltextzugriff (PDF)

Pharmacogenetic profile of lipid response to atorvastatin in children and adolescents with familial Hypercholesterolemia

Clinical therapeutics, 2015-08, Vol.37 (8), p.e6-e7

2015

Volltextzugriff (PDF)

66 Clinical validity of new genetic biomarkers of irinotecan neutropenia: An independent replication study

European journal of cancer (1990), 2014-11, Vol.50, p.26-27

2014

Volltextzugriff (PDF)

5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients

Bone (New York, N.Y.), 2012-06, Vol.50 (6), p.1260-1265

2012

Volltextzugriff (PDF)

C-kit Asp-816-Val mutation analysis in patients with mastocytosis

Dermatology (Basel), 2007-01, Vol.214 (1), p.15

2007

Volltextzugriff (PDF)

Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study

Arteriosclerosis, thrombosis, and vascular biology, 2008-04, Vol.28 (4), p.771

2008

Volltextzugriff (PDF)

Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia

Leukemia research, 2010-02, Vol.34 (2), p.154-159

2010

Volltextzugriff (PDF)

A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype‐Based With Body‐Weight‐Based Tacrolimus Dosing After Living Donor Kidney Transplantation

American journal of transplantation, 2016-07, Vol.16 (7), p.2085-2096

2016

Volltextzugriff (PDF)

Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy

The Journal of molecular diagnostics : JMD, 2021-09, Vol.23 (9), p.1047-1064

2021

Volltextzugriff (PDF)

71P Capecitabine-induced adverse events: A pharmacogenetic study beyond DPYD

Annals of oncology, 2022-09, Vol.33, p.S574

2022

Volltextzugriff (PDF)

What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? – Considerations on pre-analytical aspects by the IFCC workgroup cfDNA

Clinica chimica acta, 2021-09, Vol.520, p.168-171

2021

Volltextzugriff (PDF)

Clinical implementation of cardiovascular pharmacogenetics: Where are we?

Clinical biochemistry, 2013-08, Vol.46 (12), p.1148-1148

R.H.N., van Schaik

2013

Volltextzugriff (PDF)

TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase

The Journal of molecular diagnostics : JMD, 2022-10, Vol.24 (10), p.1051-1063

2022

Volltextzugriff (PDF)

CYP3A4 and CYP3A5 Genotyping Recommendations

The Journal of molecular diagnostics : JMD, 2023-09, Vol.25 (9), p.619-629

2023

Volltextzugriff (PDF)

Exploring P-gp as moderator of side effects and effectiveness of risperidone in children and adolescents

European neuropsychopharmacology, 2024-08, Vol.85, p.5-7

2024

Volltextzugriff (PDF)

27P Influence of single nucleotide polymorphisms (SNPs) in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer

Annals of oncology, 2022-09, Vol.33, p.S554

2022

Volltextzugriff (PDF)

Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus

The pharmacogenomics journal, 2009-08, Vol.9 (4), p.242-247

2009

Volltextzugriff (PDF)

Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe

ESMO open, 2023-04, Vol.8 (2), p.101197-101197, Article 101197

2023

Volltextzugriff (PDF)

70P Fluoropyrimidine (FP) dose individualization based on pretreatment uracil levels: Safety and pharmacokinetic (PK) analysis from the Alpe2U study

Annals of oncology, 2022-09, Vol.33, p.S573

2022

Volltextzugriff (PDF)

Influence of genetic variation in COMT on cisplatin-induced nephrotoxicity in cancer patients

Annals of oncology, 2019-10, Vol.30, p.v768

2019

Volltextzugriff (PDF)

1893P - Influence of genetic variation in COMT on cisplatin-induced nephrotoxicity in cancer patients

Annals of oncology, 2019-10, Vol.30, p.v768-v768

2019

Volltextzugriff (PDF)

1128P Germline variation in PDCD1 is associated with survival in metastatic melanoma after anti-PD-1 monotherapy

Annals of oncology, 2020-09, Vol.31, p.S758-S758

2020

Volltextzugriff (PDF)

Prevention of fluoropyrimidine toxicity: do we still have to try our patient's luck?

Annals of oncology, 2017-01, Vol.28 (1), p.183-183

2017

Volltextzugriff (PDF)

Recommendations for Clinical CYP2D6 Genotyping Allele Selection

The Journal of molecular diagnostics : JMD, 2021-09, Vol.23 (9), p.1047-1064

2021

Volltextzugriff (PDF)

Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study

The pharmacogenomics journal, 2016-02, Vol.16 (1), p.54-59

2016

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations

Pharmacogenetic profile of lipid response to atorvastatin in children and adolescents with familial Hypercholesterolemia

66 Clinical validity of new genetic biomarkers of irinotecan neutropenia: An independent replication study

5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients

C-kit Asp-816-Val mutation analysis in patients with mastocytosis

Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study

Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia

A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype‐Based With Body‐Weight‐Based Tacrolimus Dosing After Living Donor Kidney Transplantation

71P Capecitabine-induced adverse events: A pharmacogenetic study beyond DPYD

What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? – Considerations on pre-analytical aspects by the IFCC workgroup cfDNA

Clinical implementation of cardiovascular pharmacogenetics: Where are we?

CYP3A4 and CYP3A5 Genotyping Recommendations

Exploring P-gp as moderator of side effects and effectiveness of risperidone in children and adolescents

27P Influence of single nucleotide polymorphisms (SNPs) in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer

Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus

Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe

70P Fluoropyrimidine (FP) dose individualization based on pretreatment uracil levels: Safety and pharmacokinetic (PK) analysis from the Alpe2U study

Influence of genetic variation in COMT on cisplatin-induced nephrotoxicity in cancer patients

1893P - Influence of genetic variation in COMT on cisplatin-induced nephrotoxicity in cancer patients

1128P Germline variation in PDCD1 is associated with survival in metastatic melanoma after anti-PD-1 monotherapy

Prevention of fluoropyrimidine toxicity: do we still have to try our patient's luck?

Recommendations for Clinical CYP2D6 Genotyping Allele Selection

Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study

Suchergebnisse filtern